Infigratinib Before Surgery for the Treatment of Upper Tract Urothelial Cancer

Clinical trial NCT04228042 · TERMINATED

Trial details

NCT number: NCT04228042
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Renal Pelvis and Ureter Urothelial Carcinoma

Start date: 2020-07-28
Primary completion: 2024-04-17
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.